4D Molecular Therapeutics Inc [FDMT] Revenue clocked in at $21.99 million, up 59.38% YTD: What’s Next?
4D Molecular Therapeutics Inc [NASDAQ: FDMT] price surged by 84.62 percent to reach at $14.8. The company report on February 5, 2024 at 4:05 PM that 4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock. Goldman Sachs & Co. LLC, BofA Securities, Jefferies and